Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 121975632 | 12197563 | 2 | F | 201602 | 20160523 | 20160322 | 20160707 | PER | US-ASTRAZENECA-2016SE27692 | ASTRAZENECA | 918.00 | MON | M | Y | 116.60000 | KG | 20160707 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 121975632 | 12197563 | 1 | PS | BYETTA | EXENATIDE | 1 | Subcutaneous | 21773 | 5 | UG | SOLUTION FOR INJECTION IN PRE-FILLED PEN | BID | |||||||
| 121975632 | 12197563 | 2 | SS | BYETTA | EXENATIDE | 1 | Subcutaneous | 21773 | 10 | UG | SOLUTION FOR INJECTION IN PRE-FILLED PEN | BID | |||||||
| 121975632 | 12197563 | 3 | C | JANUVIA | SITAGLIPTIN PHOSPHATE | 1 | Oral | 0 | 50 | MG | QD | ||||||||
| 121975632 | 12197563 | 4 | C | SPIRIVA | TIOTROPIUM BROMIDE MONOHYDRATE | 1 | Respiratory (inhalation) | 0 | QD | ||||||||||
| 121975632 | 12197563 | 5 | C | BREO ELLIPTA | FLUTICASONE FUROATEVILANTEROL TRIFENATATE | 1 | Respiratory (inhalation) | 0 | QD | ||||||||||
| 121975632 | 12197563 | 6 | C | SYNTHROID | LEVOTHYROXINE SODIUM | 1 | Oral | 0 | 1 | UG | QD | ||||||||
| 121975632 | 12197563 | 7 | C | DYADIDE | 2 | Oral | 0 | 40 | MG | QD | |||||||||
| 121975632 | 12197563 | 8 | C | JALYN | DUTASTERIDETAMSULOSIN HYDROCHLORIDE | 1 | Oral | 0 | 4 | MG | QD | ||||||||
| 121975632 | 12197563 | 9 | C | MULTIVITAMIN | VITAMINS | 1 | Oral | 0 | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 121975632 | 12197563 | 1 | Type 2 diabetes mellitus |
| 121975632 | 12197563 | 2 | Type 2 diabetes mellitus |
| 121975632 | 12197563 | 3 | Type 2 diabetes mellitus |
| 121975632 | 12197563 | 4 | Chronic obstructive pulmonary disease |
| 121975632 | 12197563 | 5 | Chronic obstructive pulmonary disease |
| 121975632 | 12197563 | 6 | Thyroid disorder |
| 121975632 | 12197563 | 7 | Hypertension |
| 121975632 | 12197563 | 8 | Benign prostatic hyperplasia |
| 121975632 | 12197563 | 9 | Hypovitaminosis |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 121975632 | 12197563 | Decreased appetite | |
| 121975632 | 12197563 | Dyspepsia | |
| 121975632 | 12197563 | Feeling abnormal |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 121975632 | 12197563 | 1 | 201601 | 201602 | 0 | |
| 121975632 | 12197563 | 2 | 201602 | 0 | ||
| 121975632 | 12197563 | 3 | 2011 | 0 | ||
| 121975632 | 12197563 | 4 | 2012 | 0 | ||
| 121975632 | 12197563 | 5 | 2012 | 0 | ||
| 121975632 | 12197563 | 6 | 1996 | 0 | ||
| 121975632 | 12197563 | 7 | 2006 | 0 | ||
| 121975632 | 12197563 | 8 | 2011 | 0 |